Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEP IGIV for Cystic Fibrosis
NCT00004747Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Jul 1995
- Modality
- Biologic
01
Overview
A Phase 2 trial of mucoid exopolysaccharide P. aeruginosa immune globulin in cystic fibrosis (CF), sponsored by National Center for Research Resources. Started Jul 1995; status: completed.
02
Drugs
mucoid exopolysaccharide P. aeruginosa immune globulin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00004747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004747.